Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial

Collapse authors list.
Butler, Christopher, Hobbs, Richard, Gbinigie, Oghenekome, Rahman, Najib M, Hayward, Gail, Richards, Duncan, Dorward, Jienchi, Lowe, David, Standing, Joseph F, Breuer, Judith et al (show 44 more authors) , Khoo, Saye ORCID: 0000-0002-2769-0967, Petrou, Stavros, Hood, Kerenza, Nguyen-Van-Tam, Jonathan S, Patel, Mahendra, Saville, Benjamin R, Marion, Joe, Ogburn, Emma, Allen, Julie, Rutter, Heather, Francis, Nick, Thomas, Nicholas, Evans, Philip, Dobson, Melissa, Madden, Tracie-Ann, Holmes, Jane, Harris, Victoria, Png, May Ee, Lown, Mark, van Hecke, Oliver, Detry, Michelle, Saunders, Christina, Fitzgerald, Mark, Berry, Nicholas, Mwandigha, Lazaro, Galal, Ushma, Jani, Bhautesh, Hart, Nigel, Butler, Daniel, Chalk, Jeremy, Lavallee, Layla, Hadley, Elizabeth, Cureton, Lucy, Benysek, Magdalena, Andersson, Monique, Coates, Maria, Barrett, Sarah, Bateman, Clare, Davies, Jennifer, Raymundo-Wood, Ivy, Ustianowski, Andrew, Carson-Stevens, Andrew, Yu, Ly-Mee and Little, Paul (2022) Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial.

PDF SSRN-id4237902.pdf - Published version Download (1MB) | Preview